Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors‐past, present, and future considerations
出版年份 2019 全文链接
标题
Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors‐past, present, and future considerations
作者
关键词
-
出版物
Andrology
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2019-03-29
DOI
10.1111/andr.12611
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acetylation of CCAR2 establishes a BET/BRD9 acetyl switch in response to combined deacetylase and bromodomain inhibition
- (2019) Praveen Rajendran et al. CANCER RESEARCH
- Biological and molecular effects of bromodomain and extra-terminal (BET) inhibitors JQ1, IBET-151 and IBET-762 in OSCC cells
- (2019) Federica Baldan et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses
- (2018) Daniela Matei et al. CLINICAL CANCER RESEARCH
- Therapeutic approaches for refractory germ cell cancer
- (2018) Christoph Oing et al. Expert Review of Anticancer Therapy
- Epigenetics and testicular germ cell tumors
- (2018) Robert Buljubašić et al. GENE
- Targeting bromodomain and extraterminal proteins in breast cancer
- (2018) Jennifer M. Sahni et al. PHARMACOLOGICAL RESEARCH
- EP-1618: Monoubiquitinylated histone H2B as a potential target in treatment resistant germ cell tumors
- (2018) C. Oing et al. RADIOTHERAPY AND ONCOLOGY
- Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
- (2018) Jay H. Kalin et al. Nature Communications
- Integrated Molecular Characterization of Testicular Germ Cell Tumors
- (2018) Hui Shen et al. Cell Reports
- Drug Design Concepts for LSD1-Selective Inhibitors
- (2018) Yosuke Ota et al. CHEMICAL RECORD
- An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis
- (2018) Andrea Necchi et al. EUROPEAN UROLOGY
- Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group
- (2018) Martin Fenner et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Recent global trends in testicular cancer incidence and mortality
- (2018) Jee Soo Park et al. MEDICINE
- Palliative treatment of germ cell cancer
- (2018) Christoph Oing et al. CANCER TREATMENT REVIEWS
- 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells
- (2018) Christoph Oing et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors
- (2018) Daniel Nettersheim et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Enhanced efficacy of histone deacetylase inhibitor combined with bromodomain inhibitor in glioblastoma
- (2018) Wei Meng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pharmacological Inhibition of LSD1 for Cancer Treatment
- (2018) Guan-Jun Yang et al. MOLECULES
- Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma
- (2018) Lei Zhao et al. NEOPLASIA
- Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation
- (2017) Stefanie Zschäbitz et al. EUROPEAN JOURNAL OF CANCER
- Bromodomain Histone Readers and Cancer
- (2017) Abhinav K Jain et al. JOURNAL OF MOLECULAR BIOLOGY
- Animacroxam, a Novel Dual-Mode Compound Targeting Histone Deacetylases and Cytoskeletal Integrity of Testicular Germ Cell Cancer Cells
- (2017) Gustav Steinemann et al. MOLECULAR CANCER THERAPEUTICS
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non–Small Cell Lung Cancer
- (2017) Dennis O. Adeegbe et al. Cancer Discovery
- Targeting Cancer Cells with BET Bromodomain Inhibitors
- (2017) Yali Xu et al. Cold Spring Harbor Perspectives in Medicine
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer
- (2016) Nita Ahuja et al. Annual Review of Medicine
- The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas
- (2016) Daniel Nettersheim et al. BRITISH JOURNAL OF CANCER
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects
- (2016) J. Shahbazi et al. CLINICAL CANCER RESEARCH
- Germ cell neoplasiain situ(GCNIS): evolution of the current nomenclature for testicular pre-invasive germ cell malignancy
- (2016) Daniel M Berney et al. HISTOPATHOLOGY
- The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
- (2016) Sina Jostes et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Genetic Determinants of Cisplatin Resistance in Patients With Advanced Germ Cell Tumors
- (2016) Aditya Bagrodia et al. JOURNAL OF CLINICAL ONCOLOGY
- Testicular germ cell tumours
- (2016) Ewa Rajpert-De Meyts et al. LANCET
- BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells
- (2016) D T Saenz et al. LEUKEMIA
- Phase II study of everolimus in refractory testicular germ cell tumors
- (2016) Michal Mego et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatment
- (2016) Daniel Nettersheim et al. Oncotarget
- Targeting BET bromodomain proteins in solid tumors
- (2016) Vaibhav Sahai et al. Oncotarget
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Epigenetic polypharmacology: from combination therapy to multitargeted drugs
- (2016) Angel R. de Lera et al. Clinical Epigenetics
- Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors
- (2016) S. Shah et al. Cancer Immunology Research
- Comprehensive identification of genes driven by ERV9-LTRs reveals TNFRSF10B as a re-activatable mediator of testicular cancer cell death
- (2015) U Beyer et al. CELL DEATH AND DIFFERENTIATION
- Digging deep into “dirty” drugs – modulation of the methylation machinery
- (2015) Lisa Pleyer et al. DRUG METABOLISM REVIEWS
- Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors
- (2015) Cassy M. Spiller et al. Molecular Oncology
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- The effects of chemotherapy with bleomycin, etoposide, and cis-platinum on telomeres in rat male germ cells
- (2015) M. Liu et al. Andrology
- Genome Wide DNA Methylation Profiles Provide Clues to the Origin and Pathogenesis of Germ Cell Tumors
- (2015) Martin A. Rijlaarsdam et al. PLoS One
- Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives
- (2014) P Wongtrakoongate et al. BRITISH JOURNAL OF CANCER
- Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell Tumors
- (2014) D. R. Feldman et al. CLINICAL CANCER RESEARCH
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Seminoma and Embryonal Carcinoma Footprints Identified by Analysis of Integrated Genome-Wide Epigenetic and Expression Profiles of Germ Cell Cancer Cell Lines
- (2014) Yvonne G. van der Zwan et al. PLoS One
- Cisplatin resistance in germ cell tumours: models and mechanisms
- (2014) C. Jacobsen et al. Andrology
- The Effects of Chemotherapy with Bleomycin, Etoposide, and Cis-Platinum (BEP) on Rat Sperm Chromatin Remodeling, Fecundity and Testicular Gene Expression in the Progeny1
- (2013) Jennifer Maselli et al. BIOLOGY OF REPRODUCTION
- The PDGFRβ–AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
- (2013) M. Juliachs et al. CLINICAL CANCER RESEARCH
- A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors
- (2013) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Cancer testis antigen expression in testicular germ cell tumorigenesis
- (2013) Peter K Bode et al. MODERN PATHOLOGY
- Exposure to Bleomycin, Etoposide, and Cis-Platinum Alters Rat Sperm Chromatin Integrity and Sperm Head Protein Profile1
- (2012) Jennifer Maselli et al. BIOLOGY OF REPRODUCTION
- Deficiency in Mammalian Histone H2B Ubiquitin Ligase Bre1 (Rnf20/Rnf40) Leads to Replication Stress and Chromosomal Instability
- (2012) S. B. Chernikova et al. CANCER RESEARCH
- Epigenetic Resensitization to Platinum in Ovarian Cancer
- (2012) D. Matei et al. CANCER RESEARCH
- DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma
- (2012) Eri Arai et al. HISTOPATHOLOGY
- Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma
- (2012) Idriss M. Bennani-Baiti et al. HUMAN PATHOLOGY
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study
- (2011) K. Oechsle et al. ANNALS OF ONCOLOGY
- Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
- (2011) J. Wang et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- NANOG promoter methylation and expression correlation during normal and malignant human germ cell development
- (2011) Daniel Nettersheim et al. Epigenetics
- Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
- (2011) Karin Oechsle et al. EUROPEAN UROLOGY
- The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression
- (2011) Daniel Nettersheim et al. GENES CHROMOSOMES & CANCER
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
- (2009) N Steele et al. BRITISH JOURNAL OF CANCER
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- An operational definition of epigenetics
- (2009) S. L. Berger et al. GENES & DEVELOPMENT
- Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
- (2009) Darren R. Feldman et al. INVESTIGATIONAL NEW DRUGS
- Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors
- (2009) Friedemann Honecker et al. JOURNAL OF CLINICAL ONCOLOGY
- Rethinking how DNA methylation patterns are maintained
- (2009) Peter A. Jones et al. NATURE REVIEWS GENETICS
- Expression of BLIMP1/PRMT5 and concurrent histone H2A/H4 arginine 3 dimethylation in fetal germ cells, CIS/IGCNU and germ cell tumors
- (2008) Dawid Eckert et al. BMC DEVELOPMENTAL BIOLOGY
- HDAC family: What are the cancer relevant targets?
- (2008) Olaf Witt et al. CANCER LETTERS
- Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors
- (2008) Georges J Netto et al. MODERN PATHOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started